Streptococcus agalactiae or Group B streptococcus (GBS) is among the leading life-threating infectious agents in neonates. It is also known to cause disease in pregnant women and immunocompromised patients. The aim of the current study was to determine GBS prevalence among pregnant and non-pregnant women in Ismailia, Egypt. Four-hundred sixty-two vaginal swabs were collected from pregnant and non-pregnant women. A total of 27.9% women were found as positive GBS carriers. In respect to pregnant participants, 26% pregnant women were defined as asymptomatic GBS carriers versus 35.5% among non-pregnant participants. Age, parity, history of previous abortion or preterm labor were not significantly associated as potential risk factors for GBS carriage.
Shabayek, S. (2017). Prevalence of group B streptococcus among pregnant and non-pregnant women in Ismailia, Egypt. Records of Pharmaceutical and Biomedical Sciences, 1(1), 6-16. doi: 10.21608/rpbs.2018.5915
MLA
Sarah Shabayek. "Prevalence of group B streptococcus among pregnant and non-pregnant women in Ismailia, Egypt". Records of Pharmaceutical and Biomedical Sciences, 1, 1, 2017, 6-16. doi: 10.21608/rpbs.2018.5915
HARVARD
Shabayek, S. (2017). 'Prevalence of group B streptococcus among pregnant and non-pregnant women in Ismailia, Egypt', Records of Pharmaceutical and Biomedical Sciences, 1(1), pp. 6-16. doi: 10.21608/rpbs.2018.5915
VANCOUVER
Shabayek, S. Prevalence of group B streptococcus among pregnant and non-pregnant women in Ismailia, Egypt. Records of Pharmaceutical and Biomedical Sciences, 2017; 1(1): 6-16. doi: 10.21608/rpbs.2018.5915
)
View on SCiNiTO